San Diego Regenerative Medicine Institute releases Dr. Parsons’ testimony at Institute of Medicine Committee on a Review of the California Institute for Regenerative Medicine (CIRM) and statement to urge CIRM to use California Stem Cell Research & Cure Bond Act (Proposition71) to Fund human embryonic stem cell (hESC) research & novel stem cell therapy development of Prop71, to support hESC research leaders and stem cell research leadership activity of Prop71, to have transparent grant review and funding process, such as eliminate the biased and non-transparent pre-application, allow applicants formal appeal for pre-application, give applicants the opportunity to speak/talk about their proposals in open public meetings;
Urge California State Officials to nominate hESC research advocates and hESC therapy start-ups representatives to the ICOC board to represent the interest of Prop71;
Urge CIRM to use Prop71 funding to jumpstart hESC therapy start-ups of Prop71; urge CIRM to stop issuing conflict-of-interest RFAs to shut out stem cell research of Prop71 and hurt public’s interests, to stop using non-transparent biased grant review behind the close door to block stem cell research & therapy development of Prop71.
See Dr. Parsons’ testimony and watch the scientific merits of Prop71 in motion at SDRMI wordpress.
No comments:
Post a Comment